Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmaceutical statistics

Showing results (61-70 of 1,235) with videos related to

Pageof 124
Sort By:
Pharmaceutical Statistics|June 19, 2013
Tests of marginal homogeneity and special casesKeith Dunnigan
Pharmaceutical Statistics|July 30, 2013
Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert groupAlan Phillips, Chrissie Fletcher, Gary Atkinson, et al.
Pharmaceutical Statistics|May 17, 2012
Bonferroni-based correction factor for multiple, correlated endpointsQian Shi, Emily S Pavey, Rickey E Carter
Pharmaceutical Statistics|October 22, 2009
Missing data: discussion points from the PSI missing data expert groupTomasz Burzykowski, James Carpenter, Corneel Coens, et al.
Pharmaceutical Statistics|December 24, 2009
Potential surrogate endpoints in cancer research--some considerations and examplesS W Duffy, F P Treasure
Pharmaceutical Statistics|November 3, 2017
A simple, doubly robust, efficient estimator for survival functions using pseudo observationsJixian Wang
Pharmaceutical Statistics|November 3, 2017
The plan of enrichment designs for dealing with high placebo responseXiangmin Zhang, Yeh-Fong Chen, Roy Tamura
Pharmaceutical Statistics|November 11, 2017
A dynamic power prior for borrowing historical data in noninferiority trials with binary endpointG Frank Liu
Pharmaceutical Statistics|October 6, 2017
A Bayesian sequential design with adaptive randomization for 2-sided hypothesis testQingzhao Yu, Lin Zhu, Han Zhu
Pharmaceutical Statistics|December 29, 2018
Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysisAaron Dane, Amy Spencer, Gerd Rosenkranz, et al.
Pageof 124

Showing results (61-70 of 1,235) with videos related to

Sort By:
Pageof 124
Pharmaceutical Statistics|June 19, 2013
Tests of marginal homogeneity and special casesKeith Dunnigan
Pharmaceutical Statistics|July 30, 2013
Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert groupAlan Phillips, Chrissie Fletcher, Gary Atkinson, et al.
Pharmaceutical Statistics|May 17, 2012
Bonferroni-based correction factor for multiple, correlated endpointsQian Shi, Emily S Pavey, Rickey E Carter
Pharmaceutical Statistics|October 22, 2009
Missing data: discussion points from the PSI missing data expert groupTomasz Burzykowski, James Carpenter, Corneel Coens, et al.
Pharmaceutical Statistics|December 24, 2009
Potential surrogate endpoints in cancer research--some considerations and examplesS W Duffy, F P Treasure
Pharmaceutical Statistics|November 3, 2017
A simple, doubly robust, efficient estimator for survival functions using pseudo observationsJixian Wang
Pharmaceutical Statistics|November 3, 2017
The plan of enrichment designs for dealing with high placebo responseXiangmin Zhang, Yeh-Fong Chen, Roy Tamura
Pharmaceutical Statistics|November 11, 2017
A dynamic power prior for borrowing historical data in noninferiority trials with binary endpointG Frank Liu
Pharmaceutical Statistics|October 6, 2017
A Bayesian sequential design with adaptive randomization for 2-sided hypothesis testQingzhao Yu, Lin Zhu, Han Zhu
Pharmaceutical Statistics|December 29, 2018
Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysisAaron Dane, Amy Spencer, Gerd Rosenkranz, et al.
Pageof 124